Efficacy of sodium antimony gluconate and ketoconazole in the treatment of kala-azar - A comparative study

Journal of Communicable Diseases

Volumn 29, Issue 2, 1997, Pages 73-83

  Wali, Jyoti Prakash ^a   Aggarwal, Praveen ^a   Nandy, Amitabha ^b   Singh, Sarman ^a   Addy, Manjulika ^b   Guha, Subhasish Kamal ^b   Dwivedi, Sada Nand ^a   Karmarkar, Madhu G ^c   Maji, Ardhendu Kumar ^b  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b CALCUTTA SCHOOL OF TROPICAL MEDICINE   (India)

^c SITARAM BHARTIA INSTITUTE OF SCIENCE AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

KETOCONAZOLE;

ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MONITORING; FOLLOW UP; HEPATOMEGALY; HUMAN; LIVER FUNCTION TEST; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; SPLENOMEGALY; VISCERAL LEISHMANIASIS;

DRUG MONITORING; FOLLOW-UP STUDIES; HEPATOMEGALY; HUMANS; KETOCONAZOLE; LEISHMANIASIS, VISCERAL; LIVER FUNCTION TESTS; SPLENOMEGALY;

EID: 0031156687     PISSN: 00195138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Berman JD. Chemotherapy of leishmaniasis. Biochemical mechanisms, clinical efficacy and future strategies. Rev. Infec. Dis. 1988; 10 : 566-86.
2. Jha TK. Evaluation of allopurinol in the treatment of kala-azar occurring in north Bihar, India. Trans. Roy Soc. Trop. Med. Hyg. 1983; 77 : 204-7.
3. Murphy KJ and Bong ACW Co-trimoxazole for systemic leishmaniasis. Lancet. 1981; i : 323-4.
4. Peters W, et al. Potentiating action of rifampicin and isoniazid against Leishmania mexicana amazonensis. Lancet. 1981 ii : 1122-4.
5. Kayer PA, et al. Allopurinol in the treatment of visceral leishmaniasis. Trans. Roy. Soc. Trop. Med. Hyg. 1981 75 : 556-9.
6. Thakur CP and Sinha PK. Inefficiency of ethambutol, ethambutol plus isoniazid, INH plus rifampicin, co-trimoxazole and metronidazole in the treatment of kala-azar. J. Trop. Med. Hyg. 1989; 92 : 383-5.
7. Annonymous. The leishmaniasis. WHO Technical Report Series, 701 1984.
8. Chulay JD, Spencer HC and Mugambi M. Electrocardiographic changes during treatment of leishmaniasis with pentavalent antimony. Am. J. Trop. Med. Hyg. 1985; 34 : 702-9.
9. Janssen PD. Hepatic toxicity with therapy with ketoconazole. Am. J. Med. 1983; 74 : 80-4.
10. Lake Bakaar G. Hepatic reactions associated with ketoconazole in the United Kingdom. Br. Med. J. 1987; 294 : 419-22.
11. Kitching NH. Reduced cortisol levels in patients treated with ketoconazole. Br. Med. J. 1986; 293 : 992.
12. Pont E. Endocrinologic toxicity with ketoconazole therapy. Ann. Intern. Med. 1982; 97 : 370-2.
13. Goad LJ, Holz GG Jr. and Beach DH. Sterols of ketoconazole-inhibited Leishmania mexicana promastigotes. Mol. Biochem. Parasitol. 15 : 257-79.
14. Van den Bossche H. Hypothesis on the molecular basis of the antifungal activity of N-substituted imidazoles and triazoles. Biochem. Soc. Trans. 1983; 11 : 665-7.
15. Weinrauch L, Livshin R. and El-On. J. Cutaneous leishmaniasis : treatment with ketoconazole. Cutis. 1983; 32 : 288-9, 294.
16. Belazzong S, Ammar-Khodja A., Belkaid M and Tabat-Derraz O. La Leishaniose cutanee du nord d L'Algerie. Bull. Soc. Pathol. Exot. Filiales. 1985; 78 : 615-22.
17. Viallet J, Maclean JD and Robson H. Ketoconazole in two cases of long standing cutaneous leishmaniasis. Am. Trop. Med. Hyg. 1986; 35 : 491-5.
18. Jollife DS. Cutaneous leishmaniasis from Belize. Treatment with ketoconazole. Clin. Exp. Dermatol. 1986; 11 : 62-8.
19. Wali JP et al. Ketoconazole in treatment of visceral Leishmaniasis. Lancet. 1990; 336 : 810-1.
20. Wali JP. Ketoconazole in the treatment of antimony and pentamidine resistant kala-azar. J. Infect. Dis. 1992; 66 : 215-6.
21. Halim MA, et al. Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in a renal transplant recipient after the occurrence of pancreatitis due to stibogluconate. Clin. Infect. Dis. 1983; 16 : 397-9.
22. Thakur CP, et al. Efficacy of amphotericin B in multi-drug resistant kala-azar in children in first decade of life. Indian J. Pediatr. 1993; 60 : 29-36.
23. Rashid JR, et al. The efficacy and safety of ketoconazole in visceral leishmaniasis. East Afr. Med. J. 1994; 71 : 392-5.
24. Ayala FJ. Trypanosoma and Leishmania have clonal population structures of epidemiological significance. Biol. Res. 1993; 26 : 47-63.
25. Pogue GP, et al. Identification of intra and interspecific leishmania genetic polymorphisms by arbitrary primed polymerase chain reactions and use of polymorphic DNA to identify differentially regulated genes. Parasitol. Res. 1995; 81 : 282-90.
26. Gomes RF, et al. Leishmania braziliensis (Viannia) : genetic relationships between strains isolated from different areas of Brazil as revealed by DNA fingerprinting and RAPD. Exp. Parasitol. 1995 : 80 : 681-7.